{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:05:25Z","timestamp":1781247925666,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.neuint.2007.06.031","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T11:16:35Z","timestamp":1183634195000},"page":"307-313","source":"Crossref","is-referenced-by-count":77,"title":["Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington's disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Tiziana","family":"Bisogno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Popoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2007.06.031_bib1","first-page":"283","article-title":"The endocannabinoid system in neurodegeneration","volume":"55","author":"Battista","year":"2006","journal-title":"Ital. J. Biochem."},{"issue":"1","key":"10.1016\/j.neuint.2007.06.031_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2007.04.012","article-title":"Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes","volume":"27","author":"Battista","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2007.06.031_bib3","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2007.06.031_bib4","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2007.06.031_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuint.2005.10.009","article-title":"Presynaptic effects of anandamide and WIN55 212-2 on glutamatergic nerve endings isolated from rat hippocampus","volume":"48","author":"Cannizzaro","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2007.06.031_bib6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biopsych.2005.03.008","article-title":"Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6\/2 Huntington's disease mice","volume":"57","author":"Centonze","year":"2005","journal-title":"Biol. Psychiatry."},{"issue":"4","key":"10.1016\/j.neuint.2007.06.031_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuint.2007.06.031_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2007.06.031_bib9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuint.2007.06.031_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MOL.0b013e32803dbdec","article-title":"Endocannabinoids and the regulation of their levels in health and disease","volume":"18","author":"Di Marzo","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neuint.2007.06.031_bib11","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","article-title":"Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms","volume":"29","author":"Giuffrida","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2007.06.031_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington's disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2007.06.031_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine adenosine and GABAA receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2007.06.031_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0278-5846(01)00162-2","article-title":"The role of cannabinoids in neurodegenerative diseases","volume":"25","author":"Glass","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2007.06.031_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"issue":"25","key":"10.1016\/j.neuint.2007.06.031_bib16","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis","volume":"2005","author":"Kofalvi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2007.06.031_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neulet.2006.04.030","article-title":"Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals","volume":"403","author":"Kofalvi","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2007.06.031_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature05506","article-title":"Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models","volume":"445","author":"Kreitzer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2007.06.031_bib19","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00001756-200107200-00017","article-title":"Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease","volume":"12","author":"Lastres-Becker","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2007.06.031_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0006-8993(01)03403-5","article-title":"Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease","volume":"929","author":"Lastres-Becker","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2007.06.031_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2007.06.031_bib22","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1124\/jpet.105.093286","volume":"316","author":"Maione","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuint.2007.06.031_bib23","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.bjp.0707145","article-title":"Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors","volume":"150","author":"Maione","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2007.06.031_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2007.06.031_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1523\/JNEUROSCI.3303-06.2007","article-title":"Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice","volume":"27","author":"Marsch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2007.06.031_bib26","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2007.06.031_bib27","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuint.2007.06.031_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2005.10.003","article-title":"Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals","volume":"173","author":"Re","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.neuint.2007.06.031_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410360406","article-title":"Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus","volume":"36","author":"Richfield","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2007.06.031_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","article-title":"Biochemistry and pharmacology of endovanilloids","volume":"114","author":"Starowicz","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuint.2007.06.031_bib31","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group, 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.neuint.2007.06.031_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.12.003","article-title":"Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain","volume":"135","author":"Toth","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuint.2007.06.031_bib33","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","article-title":"Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo","volume":"15","author":"Trushina","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2007.06.031_bib34","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00018-003-3453-5","article-title":"Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain","volume":"61","author":"Valenti","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2007.06.031_bib35","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701860700191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019701860700191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T08:27:20Z","timestamp":1546763240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019701860700191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S019701860700191X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2007.06.031","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}